Androgen-deprivation therapy (ADT) has become the mainstay of treatment for metastatic prostate cancer. ADT's testosterone depletion, however, leads to side effects that impair health-related ...

Exercise Training Effective for CKD Patients A novel component of an interventional program was cognitive-behavioral counseling administered in a group setting to promote behavioral change. A ...

Androgen-deprivation therapy (ADT) is well established as the standard of care in metastatic prostate cancer (PCa) management; however, ADT has significant adverse effects (AEs) that must be addressed ...

Stage 3 prostate cancer is locally advanced, with tumors extending beyond the prostate but not metastasizing distantly.

Compared to other treatments, patients’ testosterone levels return to baseline levels faster following treatment with Orgovyx. Among patients with prostate cancer, treatment with the oral ...

Nonlinear improvement seen in relative benefit of distant metastasis, OS, with reduced benefits beyond nine to 12 months of ADT.

Stereotactic body radiotherapy delays the need for long-term androgen deprivation therapy (ADT) in many men with oligometastatic prostate cancer, a study shows.

Intensive glucose control may slow kidney disease progression in diabetics. In a small study, men on androgen deprivation therapy for prostate cancer lost weight and experienced improved hemoglobin ...

CHICAGO -- A widely available anticholinergic significantly improved hot flash symptoms in men taking androgen deprivation therapy (ADT) for their prostate cancer, a researcher reported here. In a ...